The work entitled: “Levosulpiride for the treatment of diabetic macular oedema: A phase 2 randomized clinical trial” from our clinical study protocol was published in EYE, 2023 Eye; https://doi.org/10.1038/s41433-023-02715-5. This work was selected as relevant by Optometry Advisor (https://www.optometryadvisor.com/retina-vitreous/levosulpiride-improves-vision-and-retina-structure-diabetic-macular-edema)
The PhD thesis of Magdalena Zamora received the WEIZMAN 2023 AWARD in Natural Sciences
Carmen Clapp, Juan Pablo Robles, Magdalena Zamora, Gonzalo Martínez de la Escalera, Jakob Triebel, and Thomas Bertsch are inventors of the patent application entitled: Oligopeptide that inhibits angiogenesis and vascular function. Submitted in Mexico on November 20, 2019 (MX/E/2019/079075) and in the European Union on July 7, 2020 ( PCT/EP2020/069154). Published on May 27, 2021 (WO2021098996 ).
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2021098996
With applications in EUA (US17/778,396; Exp. P2022/13828US), Japon (Exp. P2022/13827JP), China (Exp. P2022/13825CN) and Europe (EP20740261.1; Exp 109205320).
UNAM-Press release (Dirección General de Comunicación Social) regarding the development of vasoinhibin analogs with therapeutic potential
The article entitled: “The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a therapeutic orally active oligopeptide” was published in Angiogenesis and notified as a relevant discovery by a German news agency.
SUMMARY
We investigate the role of the prolactin/vasoinhibin axis on the regulation of blood blood vessels, inflammation, metabolism, growth, and tissue survival.
SELECTED AWARDS
Biotechnology Career Fellowship. Rockefeller Foundation (1989-1995); Fellow "John Simon Guggenheim Memorial Foundation (1994); Research Award of the Mexican Academy of Science (1995); Young researcher award UNAM (1995); International Research Scholar of the Howard Hughes Medical Institute (1997-2002); José Santos Ophthalmology Award (2001 and 2007); GEN award for research on defects at birth (2005 and 2008); Medical Research Award "Dr. Jorge Rosenkranz" Grupo ROCHE-SYNTEX (2006); Bienial Research Award on Ophthalmology (2006); Research award by the Mexican Chamber of Pharmaceutical Laboratories (CANIFARMA) (2008). Research Award in Diabetic Retinopathy, Mexican Health Foundation (2011). Lifetime Scientific Achievements Award, Queretaro University (2013). UNAM Award in Natural Sciences 2016 (PUN 2016). Clinical Investigation Award "Miguel Alemán Valdés" (2017). Award by the Program of Patent and Innovation (PROFOPI) 2020, UNAM. Women in Science 2021 Award to Carmen Clapp by L'Oreal-UNESCO-AMC. Emeritus Scientist of the National System of Researchers (SNI, 2022-). Farmaceutical Innovation Award 2021, 6a. Edition from Mexican Pharmaceutical Council and Health Foundation.
